Hearing loss among adults with sickle cell disease in an endemic region: a prospective case-control study

BACKGROUND: Sickle cell disease (SCD) is a common disease in the Eastern province of Saudi Arabia. One of the underreported complications of sickle cell disease is sensorineural hearing loss (SNHL). OBJECTIVES: The aim of this study was to estimate the prevalence of SNHL in patients with sickle cell...

Full description

Bibliographic Details
Main Author: Ibrahim Al Jabr
Format: Article
Language:English
Published: King Faisal Specialist Hospital and Research Centre 2016-03-01
Series:Annals of Saudi Medicine
Online Access:https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2016.135
_version_ 1818874588106326016
author Ibrahim Al Jabr
author_facet Ibrahim Al Jabr
author_sort Ibrahim Al Jabr
collection DOAJ
description BACKGROUND: Sickle cell disease (SCD) is a common disease in the Eastern province of Saudi Arabia. One of the underreported complications of sickle cell disease is sensorineural hearing loss (SNHL). OBJECTIVES: The aim of this study was to estimate the prevalence of SNHL in patients with sickle cell disease by comparison with a control group from hematological diseases, and to consider the possible options that might minimize the occurrence of SNHL. DESIGN: Prospective case-control study. SETTING: Outpatient clinics in the Eastern province over a 9-month duration from July 2014 to March 2015. PATIENTS AND METHODS: Cases were selected consecutively and controls were matched for age and sex. Means for pure tone audiometry measurements and hearing thresholds were compared. MAIN OUTCOME MEASURE(S): SNHL in patients with sickle cell disease. RESULTS: Nine patients (22.5%) had hearing loss using pure tone audiometry. The mean of pure tone averages in the patient group was 21.1 on the right side and 21.5 on the left side, while the control group average was 15.4 on the right side and 15.2 on the left side. Comparison of the means of the hearing thresholds on each side for both groups showed statistically significant differences in all frequencies. CONCLUSIONS: Hearing loss is a common complication in patients with SCD. Annual hearing assessment is highly recommended to discover this complication as early as possible. LIMITATIONS: Relatively small sample size. The study was in a single outpatient clinic. Recall bias in the number of hospital admissions in the last ten years.
first_indexed 2024-12-19T13:12:59Z
format Article
id doaj.art-b831ce1bd7f44227b5ae3cc2644ca541
institution Directory Open Access Journal
issn 0256-4947
0975-4466
language English
last_indexed 2024-12-19T13:12:59Z
publishDate 2016-03-01
publisher King Faisal Specialist Hospital and Research Centre
record_format Article
series Annals of Saudi Medicine
spelling doaj.art-b831ce1bd7f44227b5ae3cc2644ca5412022-12-21T20:19:53ZengKing Faisal Specialist Hospital and Research CentreAnnals of Saudi Medicine0256-49470975-44662016-03-0136213513810.5144/0256-4947.2016.135asm-2-135Hearing loss among adults with sickle cell disease in an endemic region: a prospective case-control studyIbrahim Al Jabr0From the Department of Otorhinolaryngology, Head and Neck Surgery King Faisal University, Eastern Province, Al-Ahsa, Saudi ArabiaBACKGROUND: Sickle cell disease (SCD) is a common disease in the Eastern province of Saudi Arabia. One of the underreported complications of sickle cell disease is sensorineural hearing loss (SNHL). OBJECTIVES: The aim of this study was to estimate the prevalence of SNHL in patients with sickle cell disease by comparison with a control group from hematological diseases, and to consider the possible options that might minimize the occurrence of SNHL. DESIGN: Prospective case-control study. SETTING: Outpatient clinics in the Eastern province over a 9-month duration from July 2014 to March 2015. PATIENTS AND METHODS: Cases were selected consecutively and controls were matched for age and sex. Means for pure tone audiometry measurements and hearing thresholds were compared. MAIN OUTCOME MEASURE(S): SNHL in patients with sickle cell disease. RESULTS: Nine patients (22.5%) had hearing loss using pure tone audiometry. The mean of pure tone averages in the patient group was 21.1 on the right side and 21.5 on the left side, while the control group average was 15.4 on the right side and 15.2 on the left side. Comparison of the means of the hearing thresholds on each side for both groups showed statistically significant differences in all frequencies. CONCLUSIONS: Hearing loss is a common complication in patients with SCD. Annual hearing assessment is highly recommended to discover this complication as early as possible. LIMITATIONS: Relatively small sample size. The study was in a single outpatient clinic. Recall bias in the number of hospital admissions in the last ten years.https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2016.135
spellingShingle Ibrahim Al Jabr
Hearing loss among adults with sickle cell disease in an endemic region: a prospective case-control study
Annals of Saudi Medicine
title Hearing loss among adults with sickle cell disease in an endemic region: a prospective case-control study
title_full Hearing loss among adults with sickle cell disease in an endemic region: a prospective case-control study
title_fullStr Hearing loss among adults with sickle cell disease in an endemic region: a prospective case-control study
title_full_unstemmed Hearing loss among adults with sickle cell disease in an endemic region: a prospective case-control study
title_short Hearing loss among adults with sickle cell disease in an endemic region: a prospective case-control study
title_sort hearing loss among adults with sickle cell disease in an endemic region a prospective case control study
url https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2016.135
work_keys_str_mv AT ibrahimaljabr hearinglossamongadultswithsicklecelldiseaseinanendemicregionaprospectivecasecontrolstudy